Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Depreciation & Amortization (CF) (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Depreciation & Amortization (CF) data on record, last reported at $106000.0 in Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 2.75% year-over-year to $106000.0; the TTM value through Dec 2025 reached $406000.0, down 0.73%, while the annual FY2025 figure was $406000.0, 18.8% down from the prior year.
  • Depreciation & Amortization (CF) reached $106000.0 in Q4 2025 per PLSE's latest filing, up from $100000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $200000.0 in Q1 2022 and bottomed at $100000.0 in Q2 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $121150.0, with a median of $100000.0 recorded in 2021.
  • Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 76.99% in 2022, then plummeted 50.0% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $151000.0 in 2021, then increased by 12.58% to $170000.0 in 2022, then dropped by 18.82% to $138000.0 in 2023, then fell by 21.01% to $109000.0 in 2024, then fell by 2.75% to $106000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $106000.0 in Q4 2025, $100000.0 in Q3 2025, and $100000.0 in Q2 2025.